Search results
Gilead progresses subject enrolment in HIV prevention trials
Clinical Trials Arena via Yahoo Finance· 14 hours agoGilead Sciences has announced the progression of subject enrolment in two Phase II collaborative...
Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis
Morningstar· 10 hours agoAccording to the National Breast Cancer Foundation, about 9% of women diagnosed with breast cancer in the United States are younger than 45 years old. While surgery and radiation rarely affect ...
... and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis - Gilead ...
Benzinga· 17 hours agoGilead Sciences, Inc. GILD, following the recent acquisition of CymaBay Therapeutics, Inc., today announced two-year interim results from the ongoing ASSURE ...
The Zacks Analyst Blog Highlights NextEra Energy, BP, Gilead Sciences, Hamilton Beach and FONAR
Zacks via Yahoo Finance· 1 day agoStocks recently featured in the blog include: NextEra Energy, Inc. NEE, BP p.l.c. BP, Gilead ...
Paulson Wealth Management Inc. Grows Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 3 days agoPaulson Wealth Management Inc. grew its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.3% in the 4th quarter, according to its most ...
Vir pressures Gilead with hepatitis D cocktail showing early efficacy in phase 2
FierceBiotech· 10 hours agoVir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase...
J&J seeks expanded approvals for paediatric HIV-1 therapy
Pharmaceutical Technology via Yahoo Finance· 14 hours agoA Phase II/III clinical trial by Gilead Sciences has established the efficacy, safety and...
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
Motley Fool via Yahoo Finance· 9 hours agoKHC Revenue (TTM) data by YCharts. The final stock on this list is biotech giant Gilead Sciences...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
... Is Arcus Biosciences Stock Trading Higher Today? - Arcus Biosciences (NYSE:RCUS), Gilead ...
Benzinga· 2 days agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free ...